The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply

Lancet. 2023 Jun 3;401(10391):1851-1852. doi: 10.1016/S0140-6736(23)00852-8.

¹ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
² Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
³ Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.

No abstract available

Publication types